UnitedHealth Group Inc. Chief Accounting Officer Dennis Andrew Stankiewicz acquired 51 shares of common stock as dividend equivalents on September 22, 2026. He directly held 10,109 shares after the transaction. The dividend equivalents relate to outstanding restricted stock units, and no Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. director Charles D. Baker acquired 15 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. Baker held 2,411 common shares directly following the transaction.
UnitedHealth Group Inc. director Timothy Patrick Flynn acquired 68 shares of common stock on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The equivalents are immediately vested and subject to the same terms as the underlying units. His reported direct holdings following the transaction were 10,943 shares; a separate entry lists 6,033 shares held indirectly by trust.
UnitedHealth Group Inc. director John H. Noseworthy acquired 46 common shares on September 22, 2026 as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and subject to the same terms as the underlying deferred stock units. His direct common-stock holdings following the transaction were 7,662 shares.
UnitedHealth Group director Scott Gottlieb acquired 5 shares of common stock on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. His directly held common-stock position after the transaction was 664 shares. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc.’s EVP & Chief Legal Officer Christopher R. Zaetta acquired 67 shares in dividend equivalents on September 22, 2026, bringing his directly held position to 15,927 shares. The dividend equivalents relate to outstanding restricted stock units, carry the same terms as those units, and are forfeited if the units do not vest.
UnitedHealth Group Inc. CEO, UHG and director Stephen J. Hemsley acquired 50 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The equivalents were immediately vested and subject to the same terms as the underlying units. Direct holdings after the transaction were 177,690 shares, including 129,541 shares transferred from trusts on August 27, 2026. Reported indirect holdings were 359 shares by a 401(k) and 877,290 shares by trusts. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. director Valerie Montgomery Rice, M.D. acquired 47 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The equivalents were immediately vested and subject to the same terms as the underlying deferred stock units. Her directly held common-stock position following the transaction was 7,923 shares. No Rule 10b5-1 plan is reported.
UNITEDHEALTH GROUP INC director Paul R. Garcia acquired 16 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents were immediately vested and subject to the same terms as the underlying deferred stock units. Garcia directly held 3,922 shares following the acquisition; reported indirect holdings were 2,146 shares by Revocable Trust, 45 by Trust 2, and 55 by Trust 3. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. director Gil Kristen acquired 10 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. Kristen directly held 2,627 shares after the acquisition and reported 3,800 shares held indirectly by trust. No Rule 10b5-1 plan is reported.